2016
DOI: 10.1002/app.43918
|View full text |Cite
|
Sign up to set email alerts
|

Dual release kinetics of antimalarials from soy protein isolate‐carbopol‐polyacrylamide based hydrogels

Abstract: The currently used antimalarials suffer from drug resistance which is hampering the global management of malaria infection. To overcome drug resistance, they are administered as combination therapies which involve combination of two or more antimalarials. In this study, chloroquine diphosphate and curcumin were encapsulated onto prepared soy protein isolate-carbopol-polyacrylamide based hydrogels. The hydrogels were pH sensitive and exhibited enhanced swelling capability at pH 7.4. The hydrogels were biodegrad… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
19
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(19 citation statements)
references
References 16 publications
0
19
0
Order By: Relevance
“…34 pH sensitive protein-carbopolpolyacrylamide based hydrogels have been used to encapsulate a combination of antimalarial drugs (one highly water soluble and the other highly insoluble) with the hydrogel allowing controlled delivery/release of both drugs. 40 Here hydrogels were designed to act as pH responsive ''smart drug carriers'' to allow controlled dual drug release, with materials fabricated using poly(L-lactide)-co-polyethyleneglycol-co-poly(L-lactide) dimethacrylates (MA-PLLA-PEG-PLLA-MA) as degradable polymeric crosslinkers along with the monomers acrylic acid (AA) and N-isopropylacrylamide (NIPAM). As model compounds the anticancer drug DOX and the antibiotic tetracycline (TET) 41,42 were loaded into the hydrogels with the dual drug loading efficiency and in vitro drug release at pH 7.4 and 1.2 examined.…”
Section: Introductionmentioning
confidence: 99%
“…34 pH sensitive protein-carbopolpolyacrylamide based hydrogels have been used to encapsulate a combination of antimalarial drugs (one highly water soluble and the other highly insoluble) with the hydrogel allowing controlled delivery/release of both drugs. 40 Here hydrogels were designed to act as pH responsive ''smart drug carriers'' to allow controlled dual drug release, with materials fabricated using poly(L-lactide)-co-polyethyleneglycol-co-poly(L-lactide) dimethacrylates (MA-PLLA-PEG-PLLA-MA) as degradable polymeric crosslinkers along with the monomers acrylic acid (AA) and N-isopropylacrylamide (NIPAM). As model compounds the anticancer drug DOX and the antibiotic tetracycline (TET) 41,42 were loaded into the hydrogels with the dual drug loading efficiency and in vitro drug release at pH 7.4 and 1.2 examined.…”
Section: Introductionmentioning
confidence: 99%
“…These results suggest that the formulation is a potential adjunct anti-malarial therapy that can be used along with standard therapy. The formulation was not toxic and it was found to be suitable for a prolonged duration [ 34 ]. Aderibigbe and Mhlwatika prepared soy protein isolates–carbopol–polyacrylamide-based gels encapsulated with chloroquine diphosphate and curcumin ( Table 1 ).…”
Section: Polymer-based Nanocarriers For Drug Deliverymentioning
confidence: 99%
“…As a result of challenges with targeting causative substances using single drug molecules, combination of different drugs has been administered optimally and at different periods of the treatment [17][18][19]. Until recently, limited researches on dual drug delivery systems have so far provided positive results [5,[20][21][22].…”
Section: Introductionmentioning
confidence: 99%